Suppressive Activity of the Chloroform Extract of Tripterygium wilfordii Hook f on Effector T Cell Activation during Hymenolepis nana Infection in Mice

American Journal of Chinese Medicine

Volumn 26, Issue 2, 1998, Pages 181-189

  Asano, Kazuhito ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROFORM; HERBACEOUS AGENT; IMMUNOSUPPRESSIVE AGENT; PLANT EXTRACT;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CESTODIASIS; DELAYED HYPERSENSITIVITY; DISEASE MODEL; DRUG EFFECT; HYMENOLEPIS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MALE; MOUSE; T LYMPHOCYTE;

ANIMALS; CHLOROFORM; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; HYMENOLEPIASIS; HYMENOLEPIS; HYPERSENSITIVITY, DELAYED; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED BALB C; PLANT EXTRACTS; T-LYMPHOCYTES;

EID: 0032254605     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X98000233     Document Type: Article

References (20)

1. Asano, K., M. Shinoda, F. Nakamura and K. Okamoto. Hymenolepis nana: passive transfer of mouse immunity by T-cell subset of phenotypeLyt-1. Exp. Parasitai. 61: 373-378,1986.
2. Asano, K., K. Muramatsu and K. Okamoto. Hymenolepis nana: adoptive transfer of protective immunity and delayed type hypersensitivity response with mesenteric lymph node cells in mice. Exp. Parasitai. 72: 24-32, 1991.
3. Asano, K. and K. Okamoto. Murine T cell clones specific for Hymenolepis nana: generation and functional analysis in vivo and in vitro. Int. J. Parasitai. 21: 891-896,1991.
4. Asano, K., K. Muramatsu, A. Ito and K. Okamoto. Macrophages in protective immunity to Hymenolepis nana in mice. Immunol Cell Biol. 70:417-420,1992.
5. Asano, K., K. Muramatsu and K. Okamoto. Lymphokine production by mesenteric lymph node cells from BALB/c mice during Hymenolepis nana infection. Int. J. Parasitai. 23: 51-56,1993.
6. Asano, K. and K. Okamoto. Transfer of T-ce!l mediated immunity to Hymenolepis nana from mother mice to their neonates. Experientia, 48: 67-71, 1992.
7. Bradford, M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Bioehem. 72: 248-254,1976.
8. Chu, W. Overview on Tripterygium wilfordii Hook /: clinical use and basic research. Chi. J. Integrated Trad. West. Med. 8: 443-445, 1988.
9. Gu, K.X. and J.R. Zheng. Pharmacology and toxicology of Tripterygium wilfordii Hook/ J. JiangsuMed. Pharm. 13: 644-645, 1987.
10. Jia, L.I. Chemistry and pharmacology and clinical application of the plants of Tripterygium family. Yao. Xue. Tong. Bao. 20: 101 -105, 1985.
11. Ito, A. The mode of pass! ve protection against Hymenolepis nana induced by serum transfer. Int. J. Parasitai.!: 67-71, 1977.
12. Ito, A. and J.D. Smyth. In: Immunology and immunopathology and Immunoprophylaxis - Immune Responses in Parasitic Infections. E.J.L. Soulsby (ed), Boca Raton, Florida: CRC Press, 1987, pp. 115-163.
13. Reed, N.D., D.D. Isaak and R.H. Jacobson. In: Proceeding the Second International Workshop on Nude Mice - The use of Nude Mice in Model Systems for Studies on Acquired Immunity to Parasitic Helminthes. T. Nomura, N. Osavva and N. Tamaoki (eds), Tokyo: University of Tokyo Press, 1977, pp. 3-16.
14. Tao, X.L., Y. Sun, Y. Dong, Y. Shi, Y.L. Xiao, H. Di and N.J. Zhang. Prospective, controlled, double-blind, crossover trial of T2 (polyglycosides extracted from Tripterygium wilfordii Hook) in the treatment of rheumatoid arthritis. Chi. J. Med. 26: 399-402, 1987.
15. Tao, X.L., L.S. Davis and P.E. Lipsky. Effect of an extract of the Chinese herbal remedy Tripterygium wilfordii Hook/on human immune responsiveness. Arthritis and Rheumatism. 34: 1274-1281,1991.
16. .Tao, X.L., J.J. Cai and P.E. Lipsky. The identity of immunosuppressive components of the ethyl acetate extract and chloroform methanol extract (T2) of Tripterygium wilfordii Hook/ J. Pharmac. Exp. Ther. 272: 1305-1312, 1995.
17. Yang, S X., H.L. Gao, S.S. Xie, W.R. Zhang and Z.Z. Long. Immunosuppression of Triptolide and its effect on skin allograft survival. Int. J. Iminunopharmac. 14: 963-969, 1992.
18. Yang, S.X., S.S. Xie, H.L. Gao, D.L. Ma and Z.Z. Long. Triptolide suppresses T-lymphocyte proliferation by inhibiting interleukin-2 receptor expression, but spares interleukin-2 production and mRNA expression. Int. J. Immimopharmac. 16: 895-904, 1994.
19. Zhang, L.X., D.L. Pan, W.J. Zhang, H.Y. Wu and W.P. Lou. Inhibitory effect of tripterine on lymphocyte proliferation in mice. Acta Pharmac. Sin. 7: 85-88, 1986.
20. Zhang, L.X., W.M. Xu, Z.F. Cao, M.Z. Mei and H.P. Yi. Effect of tripterine on synthesis and release of PGE2, and phagocytosis by macrophages. Pharmac. Clin. Chin. Master. Meet. 4: 16-21, 1988.